From pattern recognition receptor to regulator of homeostasis: The double-faced macrophage mannose receptor

被引:131
作者
Allavena, P
Chieppa, M
Monti, P
Piemonti, L
机构
[1] Mario Negri Inst Pharmacol Res, Dept Immunol & Cell Biol, I-20157 Milan, Italy
[2] Ist Sci San Raffaele, Ctr B Cell Replacement, Telethon Juvenile Diabet Res Fdn, I-20132 Milan, Italy
关键词
C-type lectin receptors; mannose receptors; pattern recognition receptors; dendritic cells; macrophages; tumor-associated macrophages; MUC1;
D O I
10.1615/CritRevImmunol.v24.i3.20
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mannose receptor (MR) is an endocytic and phagocytic receptor belonging to the C-type lectin superfamily. A number of functions have been ascribed to this receptor, which is involved in innate and adaptive immune responses. The MR binds carbohydrate moieties on several pathogens, such as bacteria, fungi, parasites, and viruses, and, therefore, is considered a pattern recognition receptor (PRR). In addition, MR binds endogenous molecules and was originally described as a membrane-associated component binding lysosomal glycosidases in alveolar macrophages. Since its identification more than 25 years ago, many other endogenous ligands were described, including hormones, enzymes, cell membranes, extracellular matrix components, and normal as well as tumoral mucins. The MR is preferentially expressed on immune cells of myeloid lineage, especially subsets of dendritic cells (DC) and tissue macrophages. In addition to immune cells, specialized endothelial cells are also MR-positive. Increasing evidence shows that the MR is involved in the silent clearance of inflammatory molecules. In this review, we discuss current knowledge about the receptor and show that endogenous ligands activate an anti-inflammatory and tolerogenic program in DC and macrophages, thus reinforcing the hypothesis that the MR has an important role in the maintenance of homeostasis.
引用
收藏
页码:179 / 192
页数:14
相关论文
共 113 条
  • [1] Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
  • [2] 2-4
  • [3] Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses
    Apostolopoulos, V
    Barnes, N
    Pietersz, GA
    McKenzie, IFC
    [J]. VACCINE, 2000, 18 (27) : 3174 - 3184
  • [4] The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages
    Astarie-Dequeker, C
    N'Diaye, EN
    Le Cabec, V
    Rittig, MG
    Prandi, J
    Maridonneau-Parini, I
    [J]. INFECTION AND IMMUNITY, 1999, 67 (02) : 469 - 477
  • [5] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [6] Differential responses of human mononuclear phagocytes to mycobacterial lipoarabinomannans: Role of CD14 and the mannose receptor
    Bernardo, J
    Billingslea, AM
    Blumenthal, RL
    Seetoo, KF
    Simons, ER
    Fenton, MJ
    [J]. INFECTION AND IMMUNITY, 1998, 66 (01) : 28 - 35
  • [7] BERTON G, 1983, IMMUNOLOGY, V49, P705
  • [8] Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator
    Biessen, EAL
    vanTeijlingen, M
    Vietsch, H
    BarrettBergshoeff, MM
    Bijsterbosch, MK
    Rijken, DC
    vanBerkel, TJC
    Kuiper, J
    [J]. CIRCULATION, 1997, 95 (01) : 46 - 52
  • [9] MACROPHAGE COMPLEMENT AND LECTIN-LIKE RECEPTORS BIND LEISHMANIA IN THE ABSENCE OF SERUM
    BLACKWELL, JM
    EZEKOWITZ, RAB
    ROBERTS, MB
    CHANNON, JY
    SIM, RB
    GORDON, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (01) : 324 - 331
  • [10] DOES THE INDUCTION OF MACROPHAGE LYSOSOMAL-ENZYME SECRETION BY ZYMOSAN INVOLVE THE MANNOSE RECEPTOR
    BODMER, JL
    DEAN, RT
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 113 (01) : 192 - 198